Expert Insights
Channels
Themes
Active ETFs
ETF Investing
Alternatives
ETF Strategist
Artificial Intelligence
ETF Yield
Beyond Basic Beta
Financial Literacy
China Insights
Fixed Income
Climate Insights
Free Cash Flow
Core Strategies
Innovative ETFs
Crypto
Institutional Income Strategies
Disruptive Technology
Leveraged & Inverse
Energy Infrastructure
Modern Alpha
ETF Building Blocks
Portfolio Construction
ETF Education
Tax Efficient Income
Asset Class
Equity
Emerging Market Equities
Int'l Developed
U.S. Equity
Fixed Income
High Yield Corporates
Int'l Fixed Income
Investment Grade Corporates
US Treasuries & TIPS
Alternatives
Commodities
Currency
Gold/Silver/Critical Minerals
Volatility
ETF Ecosystem
ETFs in Canada
Market Outlook
Exchange
Webcasts
Popular ETFs
SPY – SPDR S&P 500 ETF
VOO – Vanguard S&P 500 ETF
QQQ – Invesco QQQ ETF
GLD – SPDR Gold Shares ETF
IVV – iShares Core S&P 500 ETF
EFA - iShares MSCI EAFE ETF
EEM – iShares MSCI Emerging Markets ETF
IEMG – iShares Core MSCI Emerging Markets ETF
VTI – Vanguard Total Stock Market ETF
GDX - VanEck Vectors Gold Miners ETF
XLF - Financial Select Sector SPDR Fund
VEA – Vanguard FTSE Developed Markets ETF
VTV - Vanguard Value ETF
Top Gold ETFs
Top Oil ETFs
Top Commodity ETFs
Top Hedge Fund ETFs
Top Financials ETFs
Top Inverse Equities ETFs
Top High Yield Bond ETFs
Education & Media
Newsletter
New ETFs
Education Central
Videos
ETF of the Week Podcast
ETF Prime Podcast
Gaining Perspective
ETF 360 Video Series
Exchange
Events
Exchange
Fixed Income Symposium
Alternatives Symposium
Equity Symposium
Cryptocurrency Symposium
Market Outlook Symposium
Company
About VettaFi
Get VettaFi’ed
FBT
Featured
Why This Biotech ETF Leads the Pack
By
Todd Shriber
February 21, 2014
Alternative ETFs
A Healthy Look at This Week’s Most Searched ETFs
By
Todd Shriber
January 18, 2014
Featured
The Right ETF for Biotech Takeover Targets
By
Todd Shriber
January 16, 2014
Featured
The One ETF Really Benefiting From the Intercept Pharma News
By
Todd Shriber
January 9, 2014
Equity ETFs
Some of 2012’s Best Sector ETFs Kept Soaring in 2013
By
Tom Lydon
December 10, 2013
Featured
Biotech ETFs: More Tricks Than Treats in October
By
Max Chen
October 31, 2013
Featured
More M&A Deals Could Boost Biotech ETFs
By
Tom Lydon
December 11, 2012
Featured
Biotech ETFs Holding Up During Rocky November
By
Tom Lydon
November 19, 2012
Featured
U.S. Equities and Stock ETFs: The Calm after the Storm
By
Tom Lydon
November 2, 2012
Featured
Follow the Next Breakthrough Drug Makers with Biotechnology ETFs
By
Tom Lydon
August 2, 2012
Featured
Biotech ETFs Weather Market Storm
By
John Spence
May 14, 2012
Featured
Choosing the Right Biotech ETF Exposure
By
Tom Lydon
April 20, 2012
Featured
Biotech ETFs Break Out
By
John Spence
January 19, 2012
Featured
Biotech ETFs: Orexigen Hit By Regulatory Hammer
By
Tom Lydon
June 3, 2011
Featured
Teva, Cephalon Boost Biotech ETFs
By
John Spence
May 2, 2011
Featured
ETFs And A Global Approach Help Investors Access Biotech
By
Tom Lydon
March 11, 2011
Featured
5 Biotechnology ETFs to Play Innovation
By
Tom Lydon
February 22, 2011
Featured
5 ETFs That Could Move on Obama’s Budget
By
Tom Lydon
February 14, 2011
Previous
1
…
4
5
6
7
8
Next
X